Somai Pharmaceutical

4stories

12 Auglast updated

Selling US Grown Flower to Europe: What the Margin Actually Says

Written by Michael Sassano, Founder and Interim CEO, SOMAÍ Pharmaceuticals Most US cannabis companies thinking about Europe focus on the wrong number.

Michael Sassano12 August 2026

Opinion

US Cannabis Rescheduling Primed to Set Off a Global Cannabis Explosion

17 January 2024

Press releases

SOMAÍ Pharmaceuticals Opens Portugal Manufacturing Facility

27 September 2022

Opinion

With Extracts Expected To Achieve A ‘50% Share Of The EU Cannabis Market’ In The Next Few Years, Who Is Currently Leading The Field?

22 August 2022

Sections

Data & Trackers

What’s On

More

Somai Pharmaceutical

Selling US Grown Flower to Europe: What the Margin Actually Says

US Cannabis Rescheduling Primed to Set Off a Global Cannabis Explosion

SOMAÍ Pharmaceuticals Opens Portugal Manufacturing Facility

With Extracts Expected To Achieve A ‘50% Share Of The EU Cannabis Market’ In The Next Few Years, Who Is Currently Leading The Field?